Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study on Central Venous Catheters (CVC). Initiated in June 2023, this study achieved its Last Subject Last Visit (LSLV) in January 2024.
Central Venous Catheters are essential in various critical care scenarios, facilitating the administration of treatments and monitoring of patients requiring long-term care.
The focus of any PMCF study is to evaluate the performance and safety of a medical device in real-world clinical settings.
If you are seeking a partner with a proven track record in conducting high-quality clinical studies for medical devices, Axcellant is your ideal choice. We are here to offer our extensive experience and specialized expertise to support your research objectives.
Whether it’s navigating the complexities of study design, execution, or compliance, our team is equipped to deliver excellence and drive your projects to success.
We invite anyone looking for an experienced partner in medical device research to reach out. Our experience spans various types of studies, from pivotal trials to PMCF studies, all aimed at enhancing patient care through innovation and evidence-based research. Let’s discuss how we can collaborate to achieve outstanding outcomes in your next clinical study.
For further details about our services or to explore potential collaborations, please do not hesitate to contact us.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant